| 51 |
21817177 | [Newly approved drugs for Alzheimer disease: effectiveness and limitation]. | 2011 Aug |
1 |
| 52 |
21872646 | Synergistic inhibition of butyrylcholinesterase by galantamine and citalopram. | 2011 Dec |
4 |
| 53 |
22397284 | Alzheimer's dementia: current data review. | 2011 Dec |
1 |
| 54 |
20113148 | Galantamine for Alzheimer's disease. | 2010 Mar |
3 |
| 55 |
20156462 | Neurochemical basis for symptomatic treatment of Alzheimer's disease. | 2010 Sep-Oct |
2 |
| 56 |
20169037 | Galantamine-ER for the treatment of mild-to-moderate Alzheimer's disease. | 2010 Feb 2 |
2 |
| 57 |
20205672 | Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: a review of recent clinical studies. | 2010 Feb |
3 |
| 58 |
20593742 | [Oral galantamine versus rivastigmine transdermal patch: a descriptive study at a memory clinic in The Netherlands]. | 2010 Jun |
1 |
| 59 |
20658794 | Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: A retrospective cohort study. | 2010 Aug 1 |
1 |
| 60 |
21199749 | Alzheimer's disease: aging, insomnia and epigenetics. | 2010 Dec |
1 |
| 61 |
21335298 | Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease. | 2010 Oct |
1 |
| 62 |
21598738 | [Cholinesterase inhibitors for treating dementia. Review]. | 2010 |
1 |
| 63 |
18949462 | Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PET. | 2009 Jan |
1 |
| 64 |
19182463 | Pharmacological interventions in primary care: hopes and illusions. | 2009 |
1 |
| 65 |
19374459 | Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease. | 2009 |
1 |
| 66 |
19424085 | Electroencephalographic effects of galantamine in major depressive disorder. | 2009 Jun |
1 |
| 67 |
19657549 | Trospium and cognition in patients with late onset Alzheimer disease. | 2009 Oct |
1 |
| 68 |
18264153 | [Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?]. | 2008 Jan 31 |
1 |
| 69 |
18316756 | Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. | 2008 Mar 4 |
1 |
| 70 |
18686744 | Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. | 2008 |
1 |
| 71 |
18991634 | The therapeutical potential of alpha-synuclein antiaggregatory agents for dementia with Lewy bodies. | 2008 |
1 |
| 72 |
17442521 | Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease. | 2007 Jul |
1 |
| 73 |
17466645 | Effective pharmacologic management of Alzheimer's disease. | 2007 May |
1 |
| 74 |
17848422 | Evaluation of centrally acting cholinesterase inhibitor exposures in adults. | 2007 Oct |
1 |
| 75 |
17908053 | Pharmacogenetic aspects of therapy with cholinesterase inhibitors: the role of CYP2D6 in Alzheimer's disease pharmacogenetics. | 2007 Sep |
1 |
| 76 |
17926835 | Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease. | 2007 Oct |
1 |
| 77 |
18020110 | Pharmacotherapy of Alzheimer disease. | 2007 Oct |
1 |
| 78 |
16289855 | Novel tricyclic quinazolinimines and related tetracyclic nitrogen bridgehead compounds as cholinesterase inhibitors with selectivity towards butyrylcholinesterase. | 2006 Mar 15 |
2 |
| 79 |
16323253 | A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease. | 2006 Jan |
1 |
| 80 |
16373816 | Case of the month: rivastigmine (Exelon) toxicity with evidence of respiratory depression. | 2006 Jan |
1 |
| 81 |
16437436 | Galantamine for Alzheimer's disease and mild cognitive impairment. | 2006 Jan 25 |
1 |
| 82 |
16449754 | Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: preliminary findings. | 2006 Mar |
1 |
| 83 |
16533671 | Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study. | 2006 Mar 31 |
1 |
| 84 |
16720956 | Current and emerging pharmacological treatment options for dementia. | 2006 |
1 |
| 85 |
16806095 | Galantamine improves cognition in schizophrenic patients stabilized on risperidone. | 2006 Sep 15 |
1 |
| 86 |
16938240 | [Mortality-associated factors in patients with Alzheimer's disease treated with galantamine]. | 2006 Jul 8 |
1 |
| 87 |
16989488 | Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment. | 2006 Jul-Aug |
1 |
| 88 |
17032609 | [Medical treatment of Alzheimer's disease]. | 2006 Oct 2 |
1 |
| 89 |
17033976 | [Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine]. | 2006 Oct 16-31 |
1 |
| 90 |
17060346 | Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. | 2006 Nov |
1 |
| 91 |
23862185 | Galantamine for vascular cognitive impairment. | 2006 Jan 25 |
1 |
| 92 |
15654502 | Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model. | 2005 Jun |
1 |
| 93 |
15785036 | Cholinesterase inhibitor affects the amyloid precursor protein isoforms in patients with Alzheimer's disease. | 2005 |
1 |
| 94 |
15863734 | Cholinesterase inhibitors in the treatment of dementia. | 2005 Mar |
1 |
| 95 |
15883258 | Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study. | 2005 May |
1 |
| 96 |
16078659 | [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands]. | 2005 Jul |
1 |
| 97 |
16197661 | Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease. | 2005 Sep |
1 |
| 98 |
16273995 | Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study. | 2005 Sep-Oct |
1 |
| 99 |
16336020 | Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease. | 2005 |
1 |
| 100 |
17203561 | The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary. | 2005 Jan |
1 |